Heart Rhythm
Volume 7, Issue 1 , Pages 9-14 , January 2010

Incidence and predictors of mortality following ablation of ventricular tachycardia in patients with an implantable cardioverter-defibrillator

  • William H. Sauer, MD, FHRS

      Affiliations

    • Electrophysiology Section, Cardiovascular Division, Department of Medicine, University of Colorado, Aurora, Colorado
    • ,
  • Erica Zado, PA-C

      Affiliations

    • Electrophysiology Section, Cardiovascular Division, Department of Medicine, University of Pennsylvania Health System, Philadelphia, Pennsylvania
    • ,
  • Edward P. Gerstenfeld, MD

      Affiliations

    • Electrophysiology Section, Cardiovascular Division, Department of Medicine, University of Pennsylvania Health System, Philadelphia, Pennsylvania
    • ,
  • Francis E. Marchlinski, MD, FHRS

      Affiliations

    • Electrophysiology Section, Cardiovascular Division, Department of Medicine, University of Pennsylvania Health System, Philadelphia, Pennsylvania
    • ,
  • David J. Callans, MD, FHRS

      Affiliations

    • Electrophysiology Section, Cardiovascular Division, Department of Medicine, University of Pennsylvania Health System, Philadelphia, Pennsylvania
    • Corresponding Author InformationAddress reprint requests and correspondence: Dr. David J. Callans, Section of Cardiac Electrophysiology, Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, Pennsylvania 19104

Received 10 July 2009 ,Accepted 7 September 2009.

  • Image Result

    Kaplan-Meier survival curve for different rates of mortality following ablation of hemodynamically tolerated versus not tolerated ventricular tachycardia (VT).

    Kaplan-Meier survival curve for different rates of mortality following ablation of hemodynamically tolerated versus not tolerated ventricular tachycardia (VT).

  • Image Result

    Kaplan-Meier survival curve for different rates of mortality following radiofrequency ablation (RFA) before versus after January 2003. VT = ventricular tachycardia.

    Kaplan-Meier survival curve for different rates of mortality following radiofrequency ablation (RFA) before versus after January 2003. VT = ventricular tachycardia.

  • Image Result

    Kaplan-Meier survival curve for different rates of mortality following ventricular tachycardia (VT) ablation in patients with versus those without inducible nonclinical VT following VT ablation.

    Kaplan-Meier survival curve for different rates of mortality following ventricular tachycardia (VT) ablation in patients with versus those without inducible nonclinical VT following VT ablation.

 Drs. Marchlinski, Callans, and Gerstenfeld have received research funding support from St. Jude Medical and Biosense-Webster, Inc., manufacturers of ablation and mapping equipment. Drs. Marchlinski and Callans have received honoraria from Biosense-Webster.

PII: S1547-5271(09)01001-7

doi: 10.1016/j.hrthm.2009.09.014

Heart Rhythm
Volume 7, Issue 1 , Pages 9-14 , January 2010

Article Tools

* Image Usage & Resolution